lenrispodun (ITI-214) / Intra-Cellular Therapies 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   63 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lenrispodun (ITI-214) / Intra-Cellular Therapies
NCT05766813: Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Recruiting
2
132
US
Lenrispodun, Placebo
Intra-Cellular Therapies, Inc.
Parkinson Disease
09/25
10/25

Download Options